Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-26

Clinical Trial Update: Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy and safety of dupilumab for the treatment of keloids and has completed. The study provides the final outcomes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Keloid | Phase 2 | Status: COMPLETED